We first performed the ROC curve analysis of CD200, FMC7, and CD79b (markers in CLLflow score apart from CD5 or CD23) expression for CLL diagnosis in the exploratory cohort. Here, FCER2 is linked to B-cell chronic lymphocytic leukemia.